337 related articles for article (PubMed ID: 12692590)
1. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
3. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
[TBL] [Abstract][Full Text] [Related]
4. FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages.
Tigges U; Hyer EG; Scharf J; Stallcup WB
Development; 2008 Feb; 135(3):523-32. PubMed ID: 18171688
[TBL] [Abstract][Full Text] [Related]
5. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay.
Ley CD; Olsen MW; Lund EL; Kristjansen PE
Microvasc Res; 2004 Nov; 68(3):161-8. PubMed ID: 15501235
[TBL] [Abstract][Full Text] [Related]
10. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.
Kinnaird T; Stabile E; Burnett MS; Lee CW; Barr S; Fuchs S; Epstein SE
Circ Res; 2004 Mar; 94(5):678-85. PubMed ID: 14739163
[TBL] [Abstract][Full Text] [Related]
11. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.
Chen J; Zhang ZG; Li Y; Wang L; Xu YX; Gautam SC; Lu M; Zhu Z; Chopp M
Circ Res; 2003 Apr; 92(6):692-9. PubMed ID: 12609969
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells.
Schmeckpeper J; Ikeda Y; Kumar AH; Metharom P; Russell SJ; Caplice NM
Differentiation; 2009; 78(2-3):169-76. PubMed ID: 19715661
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
16. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production.
Chen X; Katakowski M; Li Y; Lu D; Wang L; Zhang L; Chen J; Xu Y; Gautam S; Mahmood A; Chopp M
J Neurosci Res; 2002 Sep; 69(5):687-91. PubMed ID: 12210835
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
18. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels.
Argraves WS; Larue AC; Fleming PA; Drake CJ
Dev Dyn; 2002 Nov; 225(3):298-304. PubMed ID: 12412012
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
20. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
